STOCK TITAN

Mentari Therapeutics (MTRI) Total Assets by Year

MTRI NASDAQ

Mentari Therapeutics, Inc. closed fiscal year 2026 with $3.0M in total assets, $2.0M in total liabilities and $1.1M in shareholder equity. Total assets fell 80.6% from the prior fiscal year. The table below carries 7 fiscal years, from 2020 to 2026, and the quarters Mentari Therapeutics, Inc. has filed alongside them.

FY2026 annual
Total Assets $3.0M
Total Liabilities $2.0M
Total Equity $1.1M
YoY -80.6%
5Y CAGR -20.9%

Ticker history: INM became MTRI (Mentari Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View INM history.

Source SEC Filings Latest period Q1 FY2027, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MTRI Balance Sheet by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY26FilingFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20Filing
Total Assets$3.0M-80.6%$15.6M+31.8%$11.8M-16.2%$14.1M+10.3%$12.8M+30.7%$9.8M+25.4%$7.8M
Total Liabilities$2.0M-8.9%$2.1M-18.0%$2.6M+29.8%$2.0M-45.6%$3.7M+54.2%$2.4M+25.0%$1.9M
Total Equity$1.1M-92.0%$13.4M+45.9%$9.2M-23.9%$12.1M+33.2%$9.1M+23.1%$7.4M+25.5%$5.9M

MTRI Balance Sheet by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'27FilingQ4'26FilingQ3'26FilingQ2'26FilingQ1'26FilingQ4'25FilingQ3'25FilingQ2'25FilingQ1'25FilingQ4'24FilingQ3'24FilingQ2'24Filing
Total Assets$1.3M-90.2%$3.0M-80.6%$9.1M-1.6%$11.2M+31.6%$13.4M+27.7%$15.6M+31.8%$9.3M$8.5M-44.3%$10.5M-4.1%$11.8M-16.2%N/A$15.3M-9.8%
Total Liabilities$2.5M+41.5%$2.0M-8.9%$2.2M-0.7%$1.6M-30.9%$1.8M-14.5%$2.1M-18.0%$2.3M$2.3M-6.6%$2.1M+54.5%$2.6M+29.8%N/A$2.5M-3.9%
Total Equity-$1.2M-110.3%$1.1M-92.0%$6.9M-1.8%$9.6M+55.1%$11.6M+38.1%$13.4M+45.9%$7.0M-36.8%$6.2M-51.6%$8.4M-12.3%$9.2M-23.9%$11.1M-10.4%$12.8M-10.9%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Mentari Therapeutics, Inc. financials

Frequently Asked Questions

Mentari Therapeutics, Inc. closed fiscal year 2026 with $3.0M in total assets, $2.0M in total liabilities and $1.1M in shareholder equity.

Mentari Therapeutics, Inc. (MTRI) total assets fell by 80.6% year over year, from $15.6M to $3.0M in fiscal year 2026.

Across the 7 fiscal years this page covers, Mentari Therapeutics, Inc. (MTRI) total assets went from $7.8M in fiscal year 2020 to $3.0M in fiscal year 2026.

Mentari Therapeutics, Inc. (MTRI) reported $1.3M in total assets in Q1 2027. This represents a decrease of 90.2% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Mentari Therapeutics, Inc. (MTRI) reported on that line in every period on record.